Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unraveling the Early Phases of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)

NCT05677880 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT05677880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05677880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unraveling the Early Phases of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Lead sponsor
University of Wisconsin, Madison
Phase
Observational
Overall status
Recruiting
Start date
June 3, 2022
Completion date
August 31, 2027
Enrollment
660 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

cadasil